Devaleryl Valsartan Impurity

• Description :

  Devaleryl Valsartan Impurity is an intermediate in the synthesis of Valsartan[1].

• UNSPSC :

  12352005

• Hazard Statement :

  H302, H315, H319, H335

• Target :

  Drug Metabolite

• Type :

  Reference compound

• Related Pathways :

  Metabolic Enzyme/Protease

• Field of Research :

  Others

• Assay Protocol :

  https://www.medchemexpress.com/devaleryl-valsartan-impurity.html

• Purity :

  99.98

• Solubility :

  DMSO : 250 mg/mL (ultrasonic)

• Smiles :

  CC(C)[C@@H](C(O)=O)NCC1=CC=C(C2=CC=CC=C2C3=NNN=N3)C=C1

• Molecular Formula :

  C19H21N5O2

• Molecular Weight :

  351.41

• Precautions :

  H302, H315, H319, H335

• References & Citations :

  [1]A Sampath, et al. Identification and characterization of potential impurities of valsartan, AT1 receptor antagonist. J Pharm Biomed Anal. 2009 Oct 15;50 (3) :405-12.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [676129-92-3]